Adamas Wins FDA OK for the First and Only Drug for Parkinson's Dyskinesia Drug Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Mark Terry, BioSpace.com… Source: BioSpace You Might Also Like Meet the Scientist Finding Success at Other Biotechs Working on Old Pfizer Compounds June 12, 2017 Jounce Names Ex-Ariad's Top Dealmaker as Its New CBO August 15, 2017 GlaxoSmithKline's Pain in China is AstraZeneca's Gain November 8, 2017
